An observational study on risk factors related to bone mineral density in patients with rheumatoid arthritis

  • Trần Thị Hằng
  • Lê Đình Tuân
  • Nguyễn Tiến Sơn

Main Article Content

Keywords

Rheumatoid arthritis, bone mineral density, glucocorticoid

Abstract

Objective: To investigate some risk factors related to the bone mineral density (BMD) at the lumbar spine and femoral neck in patients with rheumatoid arthritis (RA). Subject and method: A cross-sectional and observational study in 128 inpatients with RA at Bach Mai Hospital. Result: At the lumbar spine, the percentage of patients with osteopenia was 24.2% and that with osteoporosis was 64.8%. At the femoral neck, the former was 48.4% and the latter was 30.5%. Mean BMD of the group with BMI < 18.5 (kg/m2) was lower than that with BMI ≥ 18.5 (kg/m2) (p<0.05). Patients with less than the 2-year duration of the disease had higher BMD at both lumbar spine and femoral neck than those with disease duration of 2 - 5 years or more than 5 years; the later the disease stage was, the more reduction the BMD was (p<0.05). At both lumbar spine and femoral neck, the proportion of osteoporosis of patients with glucocorticoid usage was higher than glucocorticoid naïve ones. Patients with a higher dose of glucocorticoid and longer duration had lower BMD in comparison to those with lose dose and a shorter time of usage (p<0.05). Conclusion: The reduction of bone mineral density related to BMI, disease duration, disease stages, and glucocorticoid usage (including dose and duration of treatment) in patients with rheumatoid arthritis.


              Keywords: Rheumatoid arthritis, bone mineral density, glucocorticoid.

Article Details

References

1. Trần Ngọc Ân (2001) Chẩn đoán và điều trị Y học hiện đại. Bệnh cơ xương khớp, tập I (Viêm khớp dạng thấp).
2. Trần Thị Minh Hoa (2011) Nghiên cứu mật độ xương ở bệnh nhân viêm khớp dạng thấp điều trị tại Khoa Khớp, Bệnh viện Bạch Mai. Tạp chí Y học Thực hành, 6(767), tr. 34-37.
3. Nguyễn Thị Ngọc Lan (2010) Bệnh học cơ xương khớp nội khoa. Nhà xuất bản Giáo dục Việt Nam, Hà Nội.
4. Nguyễn Thị Nga (2008) Nghiên cứu mật độ xương cột sống thắt lưng và cổ xương đùi ở bệnh nhân mắc bệnh khớp có sử dụng glucocoticoid. Trường Đại học Y Hà Nội.
5. Cấn Xuân Quý (2011) Nghiên cứu mật độ xương ở bệnh nhân viêm khớp dạng thấp. Luận văn Thạc sĩ Y học, Trường Đại học Y Hà Nội.
6. Dadoniene J et al (2003) Disease activity and health status in rheumatoid arthritis: A case-control comparison between Norway and Lithuania. Ann Rheum Dis 62(3): 231-235.
7. Haugeberg G, Orstavik RE, Uhlig T et al (2002) Clinical decision rules in rheumatoid arthritis: Do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register. Ann Rheum Dis 61: 1085-1089.
8. Haugeberg G, Uhlig T, Falch JA et al (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the oslo county rheumatoid arthritis register. Arthritis Rheum 43(3): 522-530.
9. Sambrook (2001) Osteoporosis with low dose corticosteroids: Contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. Rheumatology 28: 1063-1067.
10. Sinigaglia L, NA, Mela Q et al (2000) A multi center cross sectional study on bone mass in Rheumatoid arthritis. Rheumatology 27: 2582-2589.